Edwards Lifesciences (EW) is scheduled to report Q1 earnings on April 22, 2026. Analysts estimate EPS of $0.72 and quarterly revenue of $1.59B.
In the most recent quarter (Q4), Edwards Lifesciences reported EPS of $0.58, missing estimates of $0.62 by 0.06%. Revenue came in at $1.57B, exceeding the estimate of $1.54B by 0.02%.
Over the last 4 quarters, Edwards Lifesciences has averaged an EPS surprise of 0.09% and a revenue surprise of 0.02%.
Analyze the earnings history of Edwards Lifesciences using advanced sorting and filters.
The chart below shows Edwards Lifesciences's reported EPS compared to analyst estimates over recent quarters.
The chart below shows Edwards Lifesciences's reported revenue compared to analyst estimates over recent quarters.
Edwards Lifesciences (EW) is scheduled to report earnings on April 22, 2026. The last reported earnings were for reported on February 10, 2026 for Q4.
The Actual EPS was $0.58, which missed the estimate of $0.62.
The Actual Revenue was $1.57B, which beat the estimate of $1.54B.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2026-02-10 | $0.58 | $0.62 | -6.45 % |
| Q3 | 2025-10-30 | $0.67 | $0.59 | 13.6 % |
| Q2 | 2025-07-24 | $0.67 | $0.62 | 8.06 % |
| Q1 | 2025-04-23 | $0.64 | $0.60 | 6.67 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2026-02-10 | $1.57B | $1.54B | 1.81 % |
| Q3 | 2025-10-30 | $1.55B | $1.50B | 3.66 % |
| Q2 | 2025-07-24 | $1.53B | $1.49B | 3.01 % |
| Q1 | 2025-04-23 | $1.41B | $1.40B | 0.71 % |